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Abstract
Background: A detailed evaluation of blood supply anatomy, especially the biliary anatomy at the hepatic hilus, is
essential to ensure a complete and curative resection for Bismuth and Corlette type III hilar cholangiocarcinoma.
The study aimed to investigate the impact of individualized preoperative planning using 3D modeling on surgical
treatment for type III hilar cholangiocarcinoma.
Methods: This was a retrospective study of patients with type III hilar cholangiocarcinoma (n = 47) who underwent
surgery at the Hepatobiliary Surgery Department of Zhujiang Hospital between March 2007 and January 2015. All
patients had undergone preoperative computed tomography (CT) examination, and 3D images were reconstructed.
Preoperative surgery simulation was performed, and the simulation was applied in the subsequent surgery. Clinical,
surgical, and pathological characteristics were compared between patients undergoing preoperative planning (n = 25)
and those who did not (n = 22). Complications were examined.
Results: Surgical time and blood loss were significantly smaller in patients with 3D reconstruction compared to those
without. The number of bile duct orifices was correctly estimated in 14/25 (56.0 %) patients with preoperative planning.
The width of the hepatic surgical margin could be measured for 18 hepatic ducts, and 17 (68.0 %) of them were
pathologically diagnosed as margin-negative.
Conclusions: This technique has the advantages of precise visualization of the anatomic structures and 3D assessment
of biliary branches and vessels, allowing improved operative planning for the treatment of hilar cholangiocarcinoma.
Keywords: Hilar cholangiocarcinoma, Type III, Computed tomography, Three-dimensional reconstruction, Preoperative
planning
Background
Hilar cholangiocarcinoma accounts for 58–75 % of the
cancers of the extrahepatic biliary duct, and its incidence
shows an increasing trend, especially in Hispanic and
Asian men [1, 2]. Surgical resection is the main treatment
for hilar cholangiocarcinoma [1–3], but the resection rate
is reported to be less than 40 % [1, 2, 4]. The reasons for
non-resectability in these patients are local extensive inva-
sion to major vessels such as the hepatic artery and the
portal vein and metastases including peritoneal dissemin-
ation, liver metastases, distant lymph nodal metastases,
and extra-abdominal metastases [1, 2, 4]. The anatomic
features of the hepatic hilus often make it easy for hilar
cholangiocarcinoma to invade major vessels [5, 6]. At the
same time, hepatic duct obstruction may lead to liver
function damage, while the preserved liver function and
the critical residual liver volume after resection are
difficult to assess accurately [1, 2, 4, 7]. Therefore, the
preoperative assessment and surgical planning of hilar
cholangiocarcinoma become extremely important [8].* Correspondence: fangchihua15@163.com
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In order to select the appropriate approach for
patients with hilar cholangiocarcinoma, it is essential to
determine the anatomic relationship between the tumor
and surrounding vessels for each patient because the sur-
gical procedure is determined by their relative positions,
which vary from a patient to another [3, 9–11]. A recently
developed 3-dimensional (3D) imaging technique allows
the detection of the extent of tumor invasion and the rela-
tionship of the tumor to the vessels and bile duct system.
Only a few studies have examined preoperative imaging
and its relation to surgical finding [12–14]. It is well
known that among the surgical protocols for hilar cholan-
giocarcinoma, the classical treatment for Bismuth-
Corlette type III hilar cholangiocarcinoma [8, 15] is hemi-
hepatectomy or extended hemihepatectomy plus hepatic
caudate lobectomy [16–18]. The longitudinal extent of re-
section can be planned based on two anatomic landmarks,
the posterior portal sagittal part (U point) and the right
posterior portal branch (P point) [10, 19]. However,
clinical experience suggests that the surgical margins are
difficult to identify by simply applying the U and P points
in case of portal vein variations.
In this retrospective study, an individualized preoperative
surgical planning process combining the 3D reconstruction
technique and classification for portal vein variations was
developed and used for patients with Bismuth-Corlette
type III hilar cholangiocarcinoma.
Methods
Patients
This was a retrospective study of 47 patients with type
III hilar cholangiocarcinoma who were selected and who
had undergone surgical treatment at the Hepatobiliary
Surgery Department of Zhujiang Hospital between
March 2007 and January 2015. Inclusion criteria were
(1) postoperative histopathological diagnosis of type III
hilar cholangiocarcinoma; (2) intraoperative diagnosis
confirmed the preoperative imaging results of type III
hilar cholangiocarcinoma; (3) absence of intrahepatic
and extrahepatic extensive metastases; (4) absence of se-
vere invasion of major vessels (main hepatic artery and
main portal vein); (5) Child-Pugh grades A or B; and (6)
the liver remnant presented more than 50 % of the func-
tional liver volume according to computed tomography
(CT) volumetric assessment.
Before surgery, all patients were informed of the treat-
ment details including procedure, risks, and complications.
Therefore, they were grouped according to whether they
accepted preoperative planning using the 3D reconstruc-
tion technique (n = 25) or not (n = 22). All surgeries and
postoperative management were overseen by the same
surgical team.
The Ethics Committee of Zhujiang Hospital of Southern
Medical University approved this retrospective study
(2007-GDYK-006). All patients signed a risk consent form
preoperatively, including acceptance to receive preopera-
tive planning with 3D reconstruction technique. Because
of the retrospective nature of the study, the need for
individual consent was waived by the committee.
Preoperative CT examination
All patients underwent enhanced CT (Philips Brilliance
256-MDCT scanner; Philips, Best, The Netherlands) to
collect 2D images, which were processed using the Mxlite-
View DICOM Viewer. Enhanced scanning was conducted
in the liver, gallbladder, pancreas, spleen, and abdominal
vessels in the plain scan phase, arterial phase, portal ven-
ous phase, and venous phase using parameters previously
described [20].
For image segmentation and 3D reconstruction,
DICOM data were imported into a self-developed abdom-
inal medical imaging software (the MI-3DVS, developed
by the authors [software copyright no.: 2008SR18798]), in
which data of the liver, vessels, and intrahepatic bile duct
are extracted using a 3D dynamic adaptive region growing
method performed using sequential automatic segmenta-
tion. The specific procedures are the following: (1) a seed
point is selected from the region of interest, and the gray
average of a 3 × 3 area around the seed point is calculated
as the initial value; (2) the target images are segmented by
adjusting the upper and lower thresholds until the liver
and its internal bile duct, hepatic artery, hepatic vein,
portal venous system, and peripheral spleen, pancreas,
gallbladder, stomach, duodenum, and other major organs
are segmented from the CT images accurately and inde-
pendently; (3) and 3D reconstruction is performed using
matching cubes algorithm in surface rendering, which is
automatically registered to obtain 3D models of the corre-
sponding structures [20, 21].
Image processing
The reconstructed 3D model was imported into the
FreeForm Modeling System (SensAbleTechnologies,
Inc., Woburn, MA, USA) for processing in order to
obtain smooth, lifelike, and stereoscopic 3D models. The
liver, hepatic vein, hepatic artery, portal vein, bile duct,
stones, abdominal vessels, and peripheral organs were
colored with different colors. Different degrees of hyali-
nization were performed to hide the other organs in
order to observe the 3D anatomic relationships for
different combinations of liver and hepatic artery, liver
and portal vein, liver and hepatic vein, liver and tumors,
etc. Then the 3D model was rotated to observe the
spatial anatomic relationships between the lesions and
the adjacent organs from different perspective. In this
study, we focused on the 3D spatial relationships of the
tumors with the hepatic bile duct, hepatic artery, portal
venous system, and hepatic venous system.
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Classification of portal venous anatomy for type III hilar
cholangiocarcinoma
Type I, also known as Cheng’s type I or the normal type,
is presented in Fig. 1a. For right hemihepatectomy, the
limit point of the left bile duct dissection was located at
B2 and B3 at the left margin of the posterior portal sagit-
tal part (U point), while the limit of bile duct dissection
was located around the bifurcation of the right anterior
portal branch and right posterior portal branch (P point)
for the left hemihepatectomy.
Type II (Fig. 1b), also known as Cheng’s type II, fea-
tures the right anterior portal vein (RAPV), right poster-
ior portal vein (RPPV), and left portal vein (LPV) that
trifurcates from the main portal vein (MPV). Since the
left main portal vein is still there, the U point can be
identified and the same method as that for type I can be
applied for right hemihepatectomy for Bismuth-Corlette
type IIIa hilar cholangiocarcinoma. However, in per-
forming left hemihepatectomy for Bismuth-Corlette type
IIIb hilar cholangiocarcinoma, the P point was moved
forward to the porta hepatis, where it was close to the
hilar branch due to a short right branch. Thus, the right
anterior and posterior portal veins were dissected, and
the hilar plate was descended in order to block and pro-
tect the right hepatic duct. The limit point of the right
hepatic duct was located at the bifurcation of the right
anterior and posterior portal veins.
The features of type III (Fig. 1c) include the following:
(1) the right posterior portal vein (RPPV) comes directly
from the main portal vein (MPV) and the left portal vein
(LPV) and right anterior portal vein (RAPV) are pre-
sented as a common trunk. For right hemihepatectomy,
the LPV and RAPV were dissected, and the RAPV could
only be cut off after the LPV was protected. The U point
was still the limit point for the dissection of the left
hepatic duct. For left hemihepatectomy, the LPV and
RAPV were dissected, and the LPV could only be cut off
after the RAPV was protected. At this time, it was
needed to continue to dissect the right liver and the hep-
atic plate was descended for blocking the right hepatic
duct and RPPV. The limit point of the right bile duct
dissection was the bifurcation of the right anterior and
posterior branches of the right hepatic duct.
Type IV (Fig. 1d), also known as Cheng’s type III,
features the RPPV directly coming from the MPV and
the RAPV coming from the LPV at or near the umbilical
point. For right hemihepatectomy, the LPV and RAPV
were dissected, and the RAPV was cut off only after
blocking the LPV, while the U point was still the limit
point of the left bile duct dissection. For left hemihepa-
tectomy, the LPV and RAPV were dissected. Under this
circumstance, it was generally needed to split part of the
liver in order to dissect the RAPV, during which the
splitting of the liver was conducted as close as possible
Fig. 1 Classification system for type III hilar cholangiocarcinoma based on the 3D modeling of the portal vein. a Type I. b Type II. c Type III. d Type IV.
RA right anterior portal vein, RP right posterior portal vein, LT left portal vein
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to the left side in order to protect the RAPV. If it was
required to continue to dissect the right liver, the hepatic
plate was descended for blocking the right hepatic duct
and RPPV, and the limit point of the right bile duct
dissection was the bifurcation of the right anterior and
posterior branches of the hepatic duct.
Example of individual 3D anatomic planning
The patient was a 47-year-old male who had been suffered
from yellowish urine and yellow sclera for 1 month. Pre-
operative total bilirubin (TBil) was 174 μmol/L, and direct
bilirubin (dbil) was 147 μmol/L. CT and magnetic reson-
ance imaging (MRI) revealed that the left hepatic duct was
mainly involved by the tumor and accompanied by
obstructive intrahepatic duct dilatation (Fig. 2a, b). Pre-
operative 3D reconstruction revealed that the mass inva-
sion mainly occurred in the left hepatic duct, which was
confirmed as Bismuth-Corlette type IIIb by 3D recon-
struction. The patients’ portal vein appeared to be Cheng’s
type II variation, where the right anterior portal vein, right
posterior portal vein, and left portal branch are directly to
the main portal vein (Fig. 2c, d).
Surgery planning
Surgery planning was based on the 3D reconstruction
technique. The reconstructed models were exported as
Standard Template Library files and imported into the
FreeForm Modeling System (SensAbleTechnologies,
Inc., Woburn, MA, USA), which was used to analyze the
spatial distribution of the anatomic structures, hepatic
artery blood supply, type of hepatocellular carcinoma,
and the variations of the hepatic artery [20, 21]. The left
hemihepatectomy and hepatic caudate lobectomy were
performed after preoperative operation simulation and
calculation of the hemihepatectomic volume (Fig. 3).
Measurement indexes
Patient demographics and clinical characteristics were
collected including age, gender, cirrhosis, bilirubin, trans-
aminase, blood platelet, albumin, clotting time, CA19-9,
CEA, Child-Pugh, number and location of tumors, PTCD,
and ERCP. These surgical variables included operative
time, intraoperative blood loss, number of tumors, encap-
sulation, satellite lesions, vascular invasion, perineural
infiltration, and pathological results. Postoperative clinical
outcomes included wound infection, bile leakage,
Fig. 2 Case study of a single patient with preoperative 3D reconstruction. The patient was a 47-year-old male patient who had been suffering
from yellowish urine and yellow sclera for 1 month. Preoperative TBil was 174 μmol/L and dbil was 147 μmol/L. a CT revealed that the left hepatic
duct was mainly involved by the tumor, and the patient was accompanied by obstructive intrahepatic duct dilatation. b 3D reconstruction of the
portal vein. c 3D visualization of the liver segments and the relationship between the tumor and intrahepatic ducts. d Relationship between the
tumor and portal vein after the liver was concealed. RA right anterior portal vein, LT left portal vein, RBD right bile duct, LBD left bile duct
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abdominal infection, pleural effusion, pulmonary infection,
hemorrhage, ascites, perioperative mortality, Tbil, albumin
(ALB), alanine aminotransferase (ALT), hemoglobin, and
CA19-9.
Statistical analysis
Statistical analysis was performed using SPSS 20.0 (IBM,
Armonk, NY, USA). Continuous data are presented as
mean ± standard deviation and were analyzed using the
Student t test. Categorical variables are presented as
frequencies and were analyzed using the chi-square
test. The diagnostic performance for hepatic artery
(portal vein) variance between CT and 3D reconstruc-
tion was analyzed using the chi-square test. Two-
sided P values <0.05 were considered significant.
Results
Characteristics of the patients
Demographics, clinical, and preoperative imaging
characteristics are presented in Table 1. The two
groups were similar for age and sex distributions,
liver function, CA19-9, CEA, number of tumors, or
proportion of patients with liver cirrhosis.
Preoperative evaluations were performed in all patients
using ultrasonography, CT, and MRI. 3D reconstruction
from CT data was done for patients who accepted it.
Intraoperative data
Table 2 presents the surgical approaches and the types of
hilar cholangiocarcinoma. These variables were similar be-
tween the two groups. There were no differences in terms
of number of tumors, encapsulation, satellite nodules, vas-
cular invasion, perineural infiltration, and pathological re-
sults. Preoperative planning reduced the operative time
and intraoperative bleeding (Table 3). The number of bile
duct orifices was correctly estimated in 14/25 (56.0 %) pa-
tients with preoperative planning. The width of the hep-
atic surgical margin could be measured for 18 hepatic
ducts, and 17 (68.0 %) of them were pathologically diag-
nosed as margin-negative.
Fig. 3 Left hemihepatectomy and hepatic caudate lobectomy were
intended to be performed after preoperative operation simulation
and calculation of the hemihepatectomic volume. a Preoperative
operation simulation to calculate the volume for hemihepatectomy.
b Operational section after left hemihepatectomy in preoperative
simulation. RA right anterior portal vein, LT left portal vein, RBD right
bile duct, LBD left bile duct






Age (years) 60.4 ± 10.4 59.0 ± 9.9 0.906
Sex, male/female 14/11 14/8 0.595
Cirrhosis, n (%) 17 (68.0) 15 (68.1) 0.989
TBIL (mmol/L) 37.8 ± 40.9 30.3 ± 46.5 0.788
ALT (U/L) 45.9 ± 21.9 50.9 ± 25.2 0.783
Platelets (10*9/L) 163.0 ± 69.2 161.2 ± 72.6 0.836
ALB (g/L) 34.5 ± 5.5 34.1 ± 6.1 0.445
Prothrombin time (s) 15.7 ± 2.9 15.6 ± 2.5 0.343
CA19-9, n (%) 16 (64.0) 16 (72.7) 0.522
CEA, n (%) 12 (48.0) 13 (59.1) 0.447
Child-Pugh, n (%) 0.510
A 9 (36.0) 10 (45.5)
B 16 (64.0) 12 (54.5)
Number of tumor sites,
n (%)a
0.820
Single 4 (16.0) 3 (13.6)
Multiple 14 (84.0) 15 (86.4)
PTCD 3 (12.0) 2 (9.1) 1.000
ERCP 1 (4.0) 1 (4.5) 1.000
TBIL total bilirubin, ALT alanine aminotransferase, AST aspartate transaminase,
ALB albumin, AFP alpha fetoprotein, PTCD percutaneous transhepatic
cholangiodrainage, ERCP endoscopic retrograde cholangio-pancreatography
aBased on preoperative CT and/or MRI
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The porta hepatis was anastomized through a chev-
ron incision at the upper abdomen, and the arteriae
hepatica communis and proper hepatic artery were
dissected to expose the portal vein, and then the por-
tal vein branches and trunk were dissected and
blocked, respectively. Combined with preoperative 3D
reconstruction, three branches were found in the por-
tal vein bifurcation, where one approached the right
side and one approached the left side, both of which
were not cut off. Dissection was continued towards
the left side, and another bifurcation was found in
the left portal branch, one entering the right anterior
lobe and another one entering the fissure sagittalis.
The left portal branch was clamped at the distal end
of the right anterior branch emitting from the trunk
of the left portal branch; the left liver was then
significantly darkened while the right liver was of a
normal color. The left portal vein was ligated and cut
off, and then the left hepatic artery and left hepatic
vein were cut off, achieving left hemihepatectomy
combined with hepatic caudate lobectomy, clearance
of hepatoduodenal ligament skeletization, right
cholangioplasty, and jejunal Roux-Y anastomosis
(Fig. 4a–c). The significance of the case study of a
single patient is to show that 3D reconstruction can
clearly show the variation of portal vein and make
clear operation planning resulting in improving the
safety of the operation to avoid the occurrence of
complications.
Table 2 Surgical approaches





I 17 16 0.724
II 4 3 1.000
III 2 2 1.000
IV 2 1 1.000
aThe type of the hilar cholangiocarcinoma based on 3D model






Operative time (min) 408.6 ± 65.9 447.3 ± 99.2 0.044
Intraoperative blood
loss (mL)
864.8 ± 321.7 985.2 ± 549.9 0.047
Number of tumorsa 1.000
Single, n (%) 21 (84.0) 18 (81.8)
Multiple, n (%) 4 (16.0) 4 (18.2)
Encapsulation, n (%)a 3 (12.0) 4 (18.2) 0.690
Satellite nodules, n (%)a 7 (28.0) 6 (19.7) 0.956
Vascular invasion, n (%)a 6 (24.0) 3 (13.6) 0.470
Perineural infiltration,
n (%)a
9 (36.0) 7 (31.8) 0.763
Pathological results, n (%) 0.715
Adenocarcinoma 21 (84.0) 17 (77.3)
Other 4 (16.0) 5 (22.7)
aBased on intraoperative findings
Fig. 4 Operational procedure: a Preoperative anatomy of porta
hepatis. b Hepatic section and right hepatic duct after left
hemihepatectomy. c Postoperative superior cholangiojejumostomy
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Postoperative data
There were no differences between the two groups in
terms of postoperative complications such as wound
infection, bile leakage, intra-abdominal abscess, pleural ef-
fusion, pulmonary infection, hemorrhage, seroperitoneum,
or perioperative mortality (Table 3). On day 3, Tbil levels
were decreased significantly in patients with 3D recon-
struction compared to those without (P < 0.05).
Discussion
Complete surgical resection is the only therapeutic strategy
offering the chance of a cure to patients with hilar cholan-
giocarcinoma [3]. A wide resection and, sometimes,
extended hemihepatectomy combined with hepatic caud-
ate lobectomy are generally required in patients with
Bismuth-Corlette type III hilar cholangiocarcinoma. A
careful preoperative planning is essential to achieve good
outcomes. This study examined the use of 3D modeling of
the liver blood flow to plan the surgery adequately. Results
showed that the number of bile duct orifices was estimated
correctly in 73.7 % of patients with preoperative planning.
The width of the hepatic surgical margin could be mea-
sured for 18 hepatic ducts, and 17 (94.4 %) of them were
pathologically diagnosed as margin-negative. This tech-
nique has the advantages of precise visualization of the
anatomic structures and multidimensional assessment of
biliary branches and vessels, allowing improved operative
planning for the treatment of hilar cholangiocarcinoma.
Factors for radical resection of hilar cholangiocarci-
noma mainly include the following: (1) the relationship
between the tumors and the limit point of bile duct
dissection; (2) the blood supply of liver remnant (artery,
portal vein); and (3) the volume and function of liver
remnant [22]. The limit point of bile duct dissection
refers to the limit part from which the bile duct can be
dissected from the parallel portal vein and hepatic artery
during hepatectomy, where the bile duct at the upstream
of the limit point is unlikely to be dissected and cut off.
The limit point of bile duct dissection is often deter-
mined according to the hepatectomy approach. For right
hepatectomy, the limit point of left bile duct dissection
is located at B2 and B3 at the left edge of the posterior
portal sagittal part (the U point). For left hepatectomy,
the limit point of bile duct dissection is located near the
bifurcation of the right anterior and posterior portal
branches (the P point). However, because of the varia-
tions of the anatomy of the portal vein, the preoperative
assessment of these variations in relation to the tumor is
essential especially for Bismuth-Corlette type III hilar
cholangiocarcinoma. In addition, many patients with
Bismuth-Corlette type III hilar cholangiocarcinoma also
suffer from cholestatic cirrhosis and they cannot tolerate
a partial hepatectomy, underlining the need for individu-
alized surgical planning.
In this study, the Bismuth-Corlette type III hilar
cholangiocarcinomas were divided into four types
according to the anatomy of the portal vein and
corresponding surgical protocols were developed. The
2D CT images were reconstructed into 3D images,
which have some advantages compared with trad-
itional imaging including clearly revealing the 3D
anatomy of the intrahepatic and extrahepatic vessels
and dilated bile duct, and a true reflection of the
degree of infiltration of the tumors. The 3D images can
better assess the areas supplied/drained by the different
artery/vein branches, as well as the resection range or the
necessity of vascular reconstruction [23].
This study showed that the use of the preoperative 3D
reconstruction led to shorter surgical time and smaller
intraoperative blood losses. These results are probably
due to an easier localization of the tumors and a
better knowledge of their interactions with the sur-
rounding tissues. In particular, it is very convenient to
know in advance the limit point of bile duct dissec-
tion and quickly identify the range of hepatectomy
during the surgery according to the preoperative
calculation of liver volume in cases of portal vein
variations.
On day 3, Tbil levels were decreased significantly in
patients with 3D reconstruction compared with those
without, which might be caused by the shorter oper-
ation time and milder liver damage. Clean and
tumor-free surgical margin is the target of radical
hepatectomy and also is the basic condition for the
prevention of recurrence. For patients with a poor
liver function, it is very important to guarantee
tumor-free surgical margins and also to retain normal
liver tissue as much as possible.
This study suffers from some limitations. Its retro-
spective nature prevents exploring some data that
were not routinely collected in the medical charts. In
addition, the use of inclusion criteria could introduce
a selection bias. Long-term follow-up was not per-
formed to determine the oncological safety. Neverthe-
less, this approach could be used together with 3D
printing technologies to improve the visualization of
the anatomical structures. Additional studies are still
necessary before implementing this technique.
Conclusions
The use of 3D reconstruction modeling for the pre-
operative planning of the surgery for Bismuth-Corlette
type III hilar cholangiocarcinoma has the advantages of
precise visualization of the anatomic structures and 3D
assessment of biliary branches and vessels, allowing
improved operative planning for the treatment of hilar
cholangiocarcinoma.
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